Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Jingguo Li, Zhengyi Yang & Biguang Tuo. (2019) Role of OCT1 in hepatocellular carcinoma. OncoTargets and Therapy 12, pages 6013-6022.
Read now
Read now
Nicolas Brosseau & Dindial Ramotar. (2019) The human organic cation transporter OCT1 and its role as a target for drug responses. Drug Metabolism Reviews 51:4, pages 389-407.
Read now
Read now
Articles from other publishers (17)
Shijin Hong, Shuai Li, Xiaoyan Meng, Ping Li, Xun Wang, Mengxiang Su, Xiaodong Liu & Li Liu. (2023) Bile duct ligation differently regulates protein expressions of organic cation transporters in intestine, liver and kidney of rats through activation of farnesoid X receptor by cholate and bilirubin. Acta Pharmaceutica Sinica B 13:1, pages 227-245.
Crossref
Crossref
Min-Chang Kim & Young-Joo Lee. (2022) Analysis of Time-Dependent Pharmacokinetics Using In Vitro–In Vivo Extrapolation and Physiologically Based Pharmacokinetic Modeling. Pharmaceutics 14:12, pages 2562.
Crossref
Crossref
Ya Zhao, Jinqiu Wang, Lijuan Liu, Yayun Wu, Qiaohong Hu & Ruizhi Zhao. (2022) Vinegar-baked Radix Bupleuri enhances the liver-targeting effect of rhein on liver injury rats by regulating transporters. Journal of Pharmacy and Pharmacology 74:11, pages 1588-1597.
Crossref
Crossref
Anne T. Nies, Elke Schaeffeler & Matthias Schwab. (2022) Hepatic solute carrier transporters and drug therapy: Regulation of expression and impact of genetic variation. Pharmacology & Therapeutics 238, pages 108268.
Crossref
Crossref
Kim L.R. Brouwer, Raymond Evers, Elizabeth Hayden, Shuiying Hu, Cindy Yanfei Li, Henriette E. Meyer zu Schwabedissen, Sibylle Neuhoff, Stefan Oswald, Micheline Piquette‐Miller, Chitra Saran, Noora Sjöstedt, Jason A. Sprowl, Simone H. Stahl & Wei Yue. (2022) Regulation of Drug Transport Proteins—From Mechanisms to Clinical Impact: A White Paper on Behalf of the International Transporter Consortium. Clinical Pharmacology & Therapeutics 112:3, pages 461-484.
Crossref
Crossref
Megan L. Koleske, Xiaomin Liang, Osatohanmwen Jessica Enogieru, Dina Buitrago & Kathleen M. Giacomini. 2022. Drug Transporters. Drug Transporters
9
32
.
Jana Krüger, Markus Breunig, Lino Pascal Pasquini, Mareen Morawe, Alexander Groß, Frank Arnold, Ronan Russell, Thomas Seufferlein, Ninel Azoitei, Hans A. Kestler, Cécile Julier, Sandra Heller, Meike Hohwieler & Alexander Kleger. (2022) Functional Genomic Screening in Human Pluripotent Stem Cells Reveals New Roadblocks in Early Pancreatic Endoderm Formation. Cells 11:3, pages 582.
Crossref
Crossref
Philip Sandoval & Bruno Hagenbuch. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
585
607
.
James Lorenzen Boyer & Carol Jean Soroka. (2021) Bile formation and secretion: An update. Journal of Hepatology 75:1, pages 190-201.
Crossref
Crossref
Giuliano Ciarimboli. (2021) Regulation Mechanisms of Expression and Function of Organic Cation Transporter 1. Frontiers in Pharmacology 11.
Crossref
Crossref
Adriano Cleis Arruda, Mauro Sérgio Perilhão, Warley Almeida Santos, Marcos Fernandes Gregnani, Alexandre Budu, José Cesar Rosa Neto, Gabriel Rufino Estrela & Ronaldo Carvalho Araujo. (2020) PPARα-Dependent Modulation by Metformin of the Expression of OCT-2 and MATE-1 in the Kidney of Mice. Molecules 25:2, pages 392.
Crossref
Crossref
Charlotte J. Green, Thomas Marjot, Jeremy W. Tomlinson & Leanne Hodson. (2018) Of mice and men: Is there a future for metformin in the treatment of hepatic steatosis?. Diabetes, Obesity and Metabolism 21:4, pages 749-760.
Crossref
Crossref
Ruba Al‐Abdulla, Elisa Lozano, Rocio I R Macias, Maria J Monte, Oscar Briz, Colm J O'Rourke, Maria A Serrano, Jesus M Banales, Matias A Avila, Maria L Martinez‐Chantar, Andreas Geier, Jesper B Andersen & Jose J G Marin. (2019) Epigenetic events involved in organic cation transporter 1‐dependent impaired response of hepatocellular carcinoma to sorafenib. British Journal of Pharmacology 176:6, pages 787-800.
Crossref
Crossref
Anabela C. Ferretti, Florencia Hidalgo, Facundo M. Tonucci, Evangelina Almada, Alejandro Pariani, María C. Larocca & Cristián Favre. (2019) Metformin and glucose starvation decrease the migratory ability of hepatocellular carcinoma cells: targeting AMPK activation to control migration. Scientific Reports 9:1.
Crossref
Crossref
Kristin Bokelmann, Jürgen Brockmöller & Mladen Tzvetkov. (2018) Impact of Promoter Polymorphisms on the Transcriptional Regulation of the Organic Cation Transporter OCT1 (SLC22A1). Journal of Personalized Medicine 8:4, pages 42.
Crossref
Crossref
Johanna Vollmar, Anja Lautem, Ellen Closs, Detlef Schuppan, Yong Ook Kim, Daniel Grimm, Jens U. Marquardt, Peter Fuchs, Beate K. Straub, Arno Schad, Dirk Gründemann, Jörn M. Schattenberg, Nadine Gehrke, Marcus A. Wörns, Jan Baumgart, Peter R. Galle & Tim Zimmermann. (2017) Loss of organic cation transporter 3 (Oct3) leads to enhanced proliferation and hepatocarcinogenesis. Oncotarget 8:70, pages 115667-115680.
Crossref
Crossref
Ji Eun Park, Gongmi Ryoo & Wooin Lee. (2017) Alternative Splicing: Expanding Diversity in Major ABC and SLC Drug Transporters. The AAPS Journal 19:6, pages 1643-1655.
Crossref
Crossref